The company has picked Goldman Sachs Group Inc., Morgan Stanley and Oversea-Chinese Banking Corp. to work on its planned initial public offering, which could raise about $200 million to $300 million, the people said. A listing in the city-state may take place as early as the end of this year and could value the firm at about $1 billion, they said.
Deliberations are ongoing and details of the first-time share sale could change, the people said, asking not to be identified as the process is private. Representatives for Advanced MedTech, Goldman Sachs, Morgan Stanley, OCBC and Temasek declined to comment.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: